We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCFT
1076
DELISTED
OneConnect Financial Technology
OCFT
$22K ﹤0.01%
+543
New +$34.4K
BPMC
1077
DELISTED
Blueprint Medicines
BPMC
$21K ﹤0.01%
201
+86
+75% +$8.01K
DNLI icon
1078
Denali Therapeutics
DNLI
$3.82B
$21K ﹤0.01%
417
+177
+74% +$9.98K
RARE icon
1079
Ultragenyx Pharmaceutical
RARE
$2.56B
$21K ﹤0.01%
232
+99
+74% +$8.95K
RY icon
1080
Royal Bank of Canada
RY
$295B
$21K ﹤0.01%
215
ALLK
1081
DELISTED
Allakos
ALLK
$20K ﹤0.01%
185
+81
+78% +$7.24K
AXDX
1082
DELISTED
Accelerate Diagnostics
AXDX
$20K ﹤0.01%
+349
New +$22.8K
BEAM icon
1083
Beam Therapeutics
BEAM
$2.7B
$20K ﹤0.01%
227
+112
+97% +$11.3K
HALO icon
1084
Halozyme
HALO
$9.9B
$20K ﹤0.01%
487
+219
+82% +$9.16K
FATE icon
1085
Fate Therapeutics
FATE
$270M
$19K ﹤0.01%
326
+140
+75% +$11K
OUT icon
1086
Outfront Media
OUT
$5.72B
$19K ﹤0.01%
747
VIR icon
1087
Vir Biotechnology
VIR
$1.49B
$19K ﹤0.01%
447
+194
+77% +$8.4K
TWST icon
1088
Twist Bioscience
TWST
$5.51B
$18K ﹤0.01%
169
+73
+76% +$8.36K
ALKS icon
1089
Alkermes
ALKS
$8.47B
$17K ﹤0.01%
553
+254
+85% +$7.18K
KOD icon
1090
Kodiak Sciences
KOD
$2.52B
$17K ﹤0.01%
176
+76
+76% +$7.02K
PACB icon
1091
Pacific Biosciences
PACB
$432M
$17K ﹤0.01%
682
+300
+79% +$8.89K
ADPT icon
1092
Adaptive Biotechnologies
ADPT
$3.6B
$16K ﹤0.01%
482
+206
+75% +$7.45K
CNQ icon
1093
Canadian Natural Resources
CNQ
$92.2B
$16K ﹤0.01%
919
-510
-36% -$8.4K
IONS icon
1094
Ionis Pharmaceuticals
IONS
$9.14B
$16K ﹤0.01%
483
+204
+73% +$7.69K
OGE icon
1095
OGE Energy
OGE
$10.2B
$16K ﹤0.01%
+500
New +$17.3K
CM icon
1096
Canadian Imperial Bank of Commerce
CM
$109B
$15K ﹤0.01%
270
ARVN icon
1097
Arvinas
ARVN
$529M
$14K ﹤0.01%
168
+74
+79% +$6.54K
ALLO icon
1098
Allogene Therapeutics
ALLO
$573M
$13K ﹤0.01%
487
+208
+75% +$4.94K
CLPR
1099
Clipper Realty
CLPR
$46.5M
$13K ﹤0.01%
1,545
+45
+3% +$367
IOVA icon
1100
Iovance Biotherapeutics
IOVA
$2.1B
$13K ﹤0.01%
531
+240
+82% +$5.66K

Similar funds

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.